A Brief History of Icotrokinra – The Making of a Unicorn

• Revisiting the history of the program from inception to initial approval
• Presenting an overview of the collaboration Johnson & Johnson, including amendments
• Showcasing a competitive landscape & comparative data (efficacy/safety)
• Highlighting the next wave of peptide therapeutics

Speakers:

Carter King

EVP

Protagonist Therapeutics, Inc.